Orchestra BioMed Holdings, Inc. Line of Credit Facility, Periodic Payment, Interest
Orchestra BioMed Holdings, Inc. (OBIO) reported Line of Credit Facility, Periodic Payment, Interest of $417.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityPeriodicPaymentInterest · last filed 2023-05-12
- Orchestra BioMed Holdings, Inc. line of credit facility, periodic payment, interest for the quarter ending 2023-03-31 was $417.00K.
| Period end | Line of Credit Facility, Periodic Payment, Interest 3 month |
|---|---|
| 2023-03-31 | $417.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |